Literature DB >> 25949917

Enhancing chemotherapy efficacy by reprogramming the senescence-associated secretory phenotype of prostate tumors: A way to reactivate the antitumor immunity.

Alberto Toso1, Diletta Di Mitri1, Andrea Alimonti2.   

Abstract

Entities:  

Keywords:  PTEN; SASP; chemotherapy; immune system; prostate tumors; senescence

Year:  2015        PMID： 25949917      PMCID： PMC4404842          DOI： 10.4161/2162402X.2014.994380

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


× No keyword cloud information.
  10 in total

1.  Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.

Authors:  Diletta Di Mitri; Alberto Toso; Jing Jing Chen; Manuela Sarti; Sandra Pinton; Tanja Rezzonico Jost; Rocco D'Antuono; Erica Montani; Ramon Garcia-Escudero; Ilaria Guccini; Sabela Da Silva-Alvarez; Manuel Collado; Mario Eisenberger; Zhe Zhang; Carlo Catapano; Fabio Grassi; Andrea Alimonti
Journal:  Nature       Date:  2014-08-24       Impact factor: 49.962

2.  Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas.

Authors:  Wen Xue; Lars Zender; Cornelius Miething; Ross A Dickins; Eva Hernando; Valery Krizhanovsky; Carlos Cordon-Cardo; Scott W Lowe
Journal:  Nature       Date:  2007-01-24       Impact factor: 49.962

3.  Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity.

Authors:  Alberto Toso; Ajinkya Revandkar; Diletta Di Mitri; Ilaria Guccini; Michele Proietti; Manuela Sarti; Sandra Pinton; Jiangwen Zhang; Madhuri Kalathur; Gianluca Civenni; David Jarrossay; Erica Montani; Camilla Marini; Ramon Garcia-Escudero; Eugenio Scanziani; Fabio Grassi; Pier Paolo Pandolfi; Carlo V Catapano; Andrea Alimonti
Journal:  Cell Rep       Date:  2014-09-25       Impact factor: 9.423

4.  Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.

Authors:  Emilie A Bard-Chapeau; Shuangwei Li; Jin Ding; Sharon S Zhang; Helen H Zhu; Frederic Princen; Diane D Fang; Tao Han; Beatrice Bailly-Maitre; Valeria Poli; Nissi M Varki; Hongyang Wang; Gen-Sheng Feng
Journal:  Cancer Cell       Date:  2011-05-17       Impact factor: 31.743

Review 5.  Pro-senescence therapy for cancer treatment.

Authors:  Caterina Nardella; John G Clohessy; Andrea Alimonti; Pier Paolo Pandolfi
Journal:  Nat Rev Cancer       Date:  2011-06-24       Impact factor: 60.716

Review 6.  Senescence in tumours: evidence from mice and humans.

Authors:  Manuel Collado; Manuel Serrano
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

7.  Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.

Authors:  Tae-Won Kang; Tetyana Yevsa; Norman Woller; Lisa Hoenicke; Torsten Wuestefeld; Daniel Dauch; Anja Hohmeyer; Marcus Gereke; Ramona Rudalska; Anna Potapova; Marcus Iken; Mihael Vucur; Siegfried Weiss; Mathias Heikenwalder; Sadaf Khan; Jesus Gil; Dunja Bruder; Michael Manns; Peter Schirmacher; Frank Tacke; Michael Ott; Tom Luedde; Thomas Longerich; Stefan Kubicka; Lars Zender
Journal:  Nature       Date:  2011-11-09       Impact factor: 49.962

8.  A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis.

Authors:  Andrea Alimonti; Caterina Nardella; Zhenbang Chen; John G Clohessy; Arkaitz Carracedo; Lloyd C Trotman; Ke Cheng; Shohreh Varmeh; Sara C Kozma; George Thomas; Erika Rosivatz; Rudiger Woscholski; Francesco Cognetti; Howard I Scher; Pier Paolo Pandolfi
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

9.  Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.

Authors:  Zhenbang Chen; Lloyd C Trotman; David Shaffer; Hui-Kuan Lin; Zohar A Dotan; Masaru Niki; Jason A Koutcher; Howard I Scher; Thomas Ludwig; William Gerald; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

Review 10.  Four faces of cellular senescence.

Authors:  Francis Rodier; Judith Campisi
Journal:  J Cell Biol       Date:  2011-02-14       Impact factor: 10.539
  10 in total
  7 in total

Review 1.  Caveolin-1, a master regulator of cellular senescence.

Authors:  Daniela Volonte; Ferruccio Galbiati
Journal:  Cancer Metastasis Rev       Date:  2020-06       Impact factor: 9.264

2.  Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells.

Authors:  Tatjana Srdic-Rajic; Juan F Santibañez; Ksenija Kanjer; Nevena Tisma-Miletic; Milena Cavic; Daniel Galun; Marko Jevric; Nevena Kardum; Aleksandra Konic-Ristic; Tamara Zoranovic
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

3.  Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-κB.

Authors:  Simona Camorani; Laura Cerchia; Monica Fedele; Eugenio Erba; Maurizio D'Incalci; Elvira Crescenzi
Journal:  Oncotarget       Date:  2018-04-13

4.  Integrated analysis of senescence-associated genes in pancreatic ductal adenocarcinoma.

Authors:  Zhi-Gang Zhu; Lei Chen; Dong-Liu Miao; Yiqi Jin; Qiong Wu
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772

5.  Prognosis and tumor immune microenvironment of patients with gastric cancer by a novel senescence-related signature.

Authors:  Guanglin Zhang; Kechen Dong; Jianping Liu; Wei Zhou
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

6.  Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer.

Authors:  Ingrid Jenny Guldvik; Lina Ekseth; Amar U Kishan; Andreas Stensvold; Else Marit Inderberg; Wolfgang Lilleby
Journal:  J Pers Med       Date:  2021-06-26

Review 7.  Cellular Senescence: Mechanisms and Therapeutic Potential.

Authors:  Zehuan Liao; Han Lin Yeo; Siaw Wen Wong; Yan Zhao
Journal:  Biomedicines       Date:  2021-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.